Literature DB >> 9539766

Unique molecular surface features of in vivo tolerized T cells.

C C Maier1, A Bhandoola, W Borden, K Yui, K Hayakawa, M I Greene.   

Abstract

Differential expression of surface markers can frequently be used to distinguish functional subsets of T cells, yet a surface phenotype unique to T cells induced into an anergic state has not been described. Here, we report that CD4 T cells rendered anergic in vivo by superantigen can be identified by loss of the 6C10 T cell marker. Inoculation of Vbeta8.1 T cell antigen receptor (TCR) transgenic mice with a Vbeta8.1-reactive minor lymphocyte-stimulating superantigen (Mls-1(a)) induces tolerance to Mls-1(a) by clonal anergy. CD4 lymph node T cells from Mls-1(a) inoculated transgenic mice enriched for the 6C10(-) phenotype neither proliferate nor produce interleukin-2 upon TCR engagement, whereas 6C10(+) CD4 T cells retain responsiveness. Analysis of T cell memory markers demonstrate that 6C10(-) T cells remain 3G11(hi) but express heterogeneous levels of CD45RB, CD62L, CD44, and the CD69 early activation marker, suggesting that T cells at various degrees of activation can be functionally anergic. These studies demonstrate that anergic T cells can be purified based on 6C10 expression permitting examination of issues concerning biochemical and biological features specific to T cell anergy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9539766      PMCID: PMC22518          DOI: 10.1073/pnas.95.8.4499

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  A cell culture model for T lymphocyte clonal anergy.

Authors:  R H Schwartz
Journal:  Science       Date:  1990-06-15       Impact factor: 47.728

Review 2.  Murine CD4+ T-cell subsets.

Authors:  K Hayakawa; R R Hardy
Journal:  Immunol Rev       Date:  1991-10       Impact factor: 12.988

3.  A characteristic Mls-1a response precedes Mls-1a anergy in vivo.

Authors:  G Dannecker; S Mecheri; L Staiano-Coico; M K Hoffmann
Journal:  J Immunol       Date:  1991-04-01       Impact factor: 5.422

Review 4.  Memory B and T cells.

Authors:  E S Vitetta; M T Berton; C Burger; M Kepron; W T Lee; X M Yin
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

5.  Clonal expansion precedes anergy and death of V beta 8+ peripheral T cells responding to staphylococcal enterotoxin B in vivo.

Authors:  H R MacDonald; S Baschieri; R K Lees
Journal:  Eur J Immunol       Date:  1991-08       Impact factor: 5.532

6.  Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity.

Authors:  S Webb; C Morris; J Sprent
Journal:  Cell       Date:  1990-12-21       Impact factor: 41.582

7.  Programmed cell death and extrathymic reduction of Vbeta8+ CD4+ T cells in mice tolerant to Staphylococcus aureus enterotoxin B.

Authors:  Y Kawabe; A Ochi
Journal:  Nature       Date:  1991-01-17       Impact factor: 49.962

8.  Altered antigen receptor signaling in anergic T cells from self-tolerant T-cell receptor beta-chain transgenic mice.

Authors:  M A Blackman; T H Finkel; J Kappler; J Cambier; P Marrack
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

9.  Influence of T cell receptor V alpha expression on Mlsa superantigen-specific T cell responses.

Authors:  M S Vacchio; O Kanagawa; K Tomonari; R J Hodes
Journal:  J Exp Med       Date:  1992-05-01       Impact factor: 14.307

10.  Natural autoantibodies to thymocytes: origin, VH genes, fine specificities, and the role of Thy-1 glycoprotein.

Authors:  K Hayakawa; C E Carmack; R Hyman; R R Hardy
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

View more
  8 in total

1.  In vivo maintenance of T-lymphocyte unresponsiveness induced by thymic medullary epithelium requires antigen presentation by radioresistant cells.

Authors:  Denis Hudrisier; Sonia Feau; Véronique Bonnet; Paola Romagnoli; Joost P M Van Meerwijk
Journal:  Immunology       Date:  2003-01       Impact factor: 7.397

2.  Expression of 3G11 epitope defines subpopulations of regulatory T cells with different suppressive potency.

Authors:  Zhao Zhao; Bogoljub Ciric; Shuo Yu; Hongmei Li; Jingxian Yang; Malek Kamoun; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  J Neurol Sci       Date:  2010-06-08       Impact factor: 3.181

3.  Differential requirements for induction of total immunoglobulin and physiological rheumatoid factor production by human peripheral blood B cells.

Authors:  W J Van Esch; C C Reparon-Schuijt; E W Levarht; C Van Kooten; F C Breedveld; C L Verweij
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

4.  Modulation of Kv channel expression and function by TCR and costimulatory signals during peripheral CD4(+) lymphocyte differentiation.

Authors:  Qing-Hua Liu; Bernd K Fleischmann; Brian Hondowicz; Curtis C Maier; Laurence A Turka; Katsuyuki Yui; Michael I Kotlikoff; Andrew D Wells; Bruce D Freedman
Journal:  J Exp Med       Date:  2002-10-07       Impact factor: 14.307

Review 5.  3G11 expression in CD4+ T cell-mediated autoimmunity and immune tolerance.

Authors:  Fang Zhou; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  Int Immunopharmacol       Date:  2010-11-24       Impact factor: 4.932

6.  Suppressor T cells regulate the nonanergic cell population that remains after peripheral tolerance is induced to the Mls-1 antigen in T cell receptor Vbeta 8.1 transgenic mice.

Authors:  H Maeda; S Fujimoto; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

Review 7.  Mechanisms of peripheral immune tolerance: conversion of the immune to the unresponsive phenotype.

Authors:  Sandra J Saouaf; Patrick J Brennan; Yuan Shen; Mark I Greene
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 8.  Anergy and suppression as coexistent mechanisms for the maintenance of peripheral T cell tolerance.

Authors:  Patrick J Brennan; Sandra J Saouaf; Mark I Greene; Yuan Shen
Journal:  Immunol Res       Date:  2003       Impact factor: 4.505

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.